Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

STUDY AND PROTOCOL NUMBER

MS-STAT2  CTU/2014/107

STUDY DETAILS

A phase 3 randomised, double-blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo, in secondary progressive multiple sclerosis, in slowing the progression of disability.

FURTHER INFORMATION

ClinicalTrials.gov Identifier: NCT03387670

Multiple Sclerosis-Simvastatin Trial 2